instructions how to enable JavaScript in your web browser

Neprilysin inhibition: a new therapeutic option for type 2 diabetes? – published online 14/05/2019

All News

We say thank you to all the referees who were so generous with their time and expertise and helped us with submissions in 2023

Click here >

In the News...

14 March 2024

Low birthweight coupled with overweight in 20s linked with ‘massive risk’ of early type 2 diabetes in men

Low birthweight (<2.5 kg/5 lbs 8oz) coupled with overweight at aged 20 years linked with…

All News

Latest Tweets

Retweet on Twitter Diabetologia Retweeted

; EASD @EASDnews ·

18 Apr 1780851654251966916

📢Training opportunity for early career diabetes researchers:

EASD Scientists Training Course 2024
Harnessing basic and clinical #science #research in #diabetes to make the greatest impact
🗓️ 27 - 31 Oct 2024
🏥 Leicester Diabetes Centre, UK

Apply now: http://www.easd.org/stc-2024.html

Reply on Twitter 1780851654251966916 Retweet on Twitter 1780851654251966916 4 Like on Twitter 1780851654251966916 4 Twitter 1780851654251966916

Retweet on Twitter Diabetologia Retweeted

; EASD @EASDnews ·

4h 1781218951621411215

60 years ago, we've started with 48 abstracts and today, we are excited to announce that we've received 1814 abstract submissions for #EASD2024! Thank you🤩👏
Let's celebrate the 60th EASD Annual Meeting - register now at exclusive early rates
👉https://www.easd.org/annual-meeting/easd-2024.html
#diabetes

Reply on Twitter 1781218951621411215 Retweet on Twitter 1781218951621411215 2 Like on Twitter 1781218951621411215 5 Twitter 1781218951621411215

; Diabetologia @DiabetologiaJnl ·

18 Apr 1780912406988009942

Up front & free to read in our May issue #editorspicks: Harnessing the power of proteomics in precision diabetes medicine http://tinyurl.com/4u5y8tx6

Reply on Twitter 1780912406988009942 Retweet on Twitter 1780912406988009942 1 Like on Twitter 1780912406988009942 8 Twitter 1780912406988009942

Top